Gufic Biosciences Limited Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Gufic Biosciences Limited Company Profile :

Gufic Biosciences Limited is an Indian company engaged in the business of manufacturing pharmaceuticals, medicinal chemicals and botanical products.

Company manufactures products in the areas of pharma, herbal/ayurvedic, consumer products and personal hygiene products. Its pharma products are Ridol Tablets, Vipro-Fe Syrup, Zad-G and Eben Tablets and Suspension. Its herbal/ayurvedic products are Sallaki tablets, Sallaki ointment, Imunocin tablets and syrup, Eugynin-L tablets, Aswal Plus tablets, and Kofend syrup. Its consumer products are Stretch Nil lotion, Roll-On cold rub oil, Care ointment and cream. Its personal hygiene products are Shapers and Actislim sanitary napkins.

Company also has a tissue culture facility for the production of around five million plants per annum. This tissue culture facility is used in the production of banana, potato, sugarcane, date palm, jatropha for Indian market.


Gufic Biosciences ResultsBSE Code : 509079
NSE Symbol : GUFICBIO
ISIN No. : INE742B01025
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Gufic Biosciences or you are an stock market analyst then i am sure you might for Quarterly Results of Gufic Biosciences.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Gufic Biosciences. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Gufic Biosciences.

Gufic Biosciences Q1 Results 2017-18 :

Gufic Biosciences will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Gufic Biosciences will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Gufic Biosciences will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Gufic Biosciences will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Gufic Biosciences will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Gufic Biosciences Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Gufic Biosciences Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.